|Day Low/High||77.02 / 78.36|
|52 Wk Low/High||64.18 / 86.72|
Bassett encourages people with type 2 diabetes and their loved ones to take and share the Heart You Quiz to learn more about the No. 1 killer of people with this condition
While hard at work in Washington, a handful of members of Congress have also been busy trading stocks.
Insurance industry veteran will lead Lilly public affairs and lobbying efforts
Doug Kass shares his thoughts on Facebook, Allergan and Eli Lilly.
Eli Lilly stock is trading near its 52-week high and is 'well above peer-average multiples,' Argus said.
Another big rally made for a day of milestones: the Dow and S&P 500 enjoyed their best back-to-back gains of the year, while the Nasdaq scored a new record.
Estimates for erenumab annual sales run as high as $2.3 billion.
Better-than-expected earnings from industry leaders including Caterpillar and McDonald's push the Dow to log triple-digit gains for the second day in a row, its best two-day stretch of the year.
Eli Lilly's EPS for the 2017 first quarter was slightly better than analysts expected.
A stream of positive earnings reports keep stocks on the rise on Tuesday with the Dow Jones Industrial Average logging triple-digit gains for the second day in a row.
Stock futures move higher on Tuesday, extending gains seen a day earlier, after a series of positive earnings results from the likes of DuPont, Novartis, and Rite Aid.
Some kind of spending deal will have to be in place by Saturday in order to avoid the mayhem.
European stocks extended gains Tuesday as global markets continued to rally in the wake of Emmanuel Macron's victory in Sunday's presidential elections in France and improving corporate earnings.
European stocks are expected to extend gains Tuesday as global markets continue to rally in the wake of Emmanuel Macron's victory in Sunday's presidential elections in France.
Cramer shares his views on the preponderance of evidence, and suggests having faith in interational strength.
Full-steam ahead for earnings season in the coming week as a range of industry leaders across a swath of sectors release their recent quarterly performances.
Jim Cramer looks at how the French elections are smacking the U.S stock markets. Plus, he has the week-ahead game plan for oil and stocks.
IBM's busted turnaround and difficult transition story shaved more than 50 points off the Dow, says Jim Cramer.
Stocks close in positive territory Monday ahead of a big week for U.S. corporate earnings.
Stocks remained in positive territory breaking a three-day losing streak ahead of U.S. corporate earnings this week, despite mounting tension between North Korea and the U.S.
JNJ's diabetes and oncology franchises will also be key when the New Brunswick, N.J.-based healthcare giant reports first-quarter numbers Tuesday morning.